Tag: AI

ICON will use Intel Pharma Analytics Platform in clinical trials

clinical trials
ICON, a global provider of drug development solutions, agreed on preliminary deal terms with Intel Corporation to enable ICON to offer the Intel Pharma Analytics Platform for use in clinical trials.

BenevolentAI received financing to push forward AI enabled drug development

The company will use the funds to significantly scale its drug development activities, broaden the disease areas on which it focuses, and extend its AI platform capabilities even further.

Atomwise startup aims to become the key AI partner for pharma and biotech

Artificial Intelligence
Atomwise Inc., the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery raised $45 million of growth funding, led by Monsanto Growth Ventures, DCVC, and B Capital Group.

Microsoft and Apollo Hospitals join forces to develop AI network for healthcare

Tech giant Microsoft and leading Indian speciality hospital, Apollo Hospitals, will work to develop and deploy new machine learning models to predict patient risk for heart disease and assist doctors on treatment plans.

South Korea will support AI drug development

drug discovery
South Korea’s largest biopharmaceutical business association has kickstarted preparations for a support center that will leverage artificial intelligence to help pharmaceutical companies accelerate new drug development processes

BenevolentAI acquired a new R&D facility on the Babraham Research Campus

drug discovery
BenevolentAI, one of the world’s largest private AI companies, acquired a state-of-the-art drug discovery and development facility on the Babraham Research Campus in Cambridge (UK) for an undisclosed sum.

UK blockchain startup teams up with Mongolian government to stop fake medicines

fake drugs
FarmaTrust, a UK blockchain startup, has officially signed a partnership with the Mongolian government to pilot a one-year project aimed at preventing the creation and distribution of counterfeit medications.

Drug discovery IT solutions will reach $5.3 billion globally by 2020

The latest analysis by Frost & Sullivan highlights the growing interest in big data analytics and artificial intelligence-based solutions

WuXi NextCODE and Rhythm Pharmaceuticals started a partnership

WuXi NextCODE, the emerging global standard platform for genomic data, announced a partnership with Rhythm Pharmaceuticals

New machine learning model could significantly speed up drug discovery

drug discovery
Drug discovery could be significantly accelerated thanks to a new machine-learning model, developed by an international collaboration of researchers

Insilico Medicine and GSK set up a collaboration focused on AI drug discovery

drug discovery
Insilico Medicine announced that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process

Primer Capital invested 11 million rubles in TeleMD project

Primer Capital, a venture biotech fund, invested 11 million rubles in TeleMD project. This is a software-based platform that uses artificial intelligence to diagnose and assess the risks of oncological diseases

Juvenescence and Insilico launched a joint venture focused on AI drug discovery

Juvenescence Limited announced the launch of a joint venture with Insilico Medicine, Inc., a Baltimore-based company using artificial intelligence